Julie M. Vose, MD
Nebraska Medical Center, Omaha, NE, USA · University of Nebraska
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Julie M. Vose, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:48 UTC. Open this list on ClinicalTrials.gov
- N/ANCT02553447 · Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D DeficiencyUniversity of Nebraska · completed · Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Untreated Chronic Lymphocytic Leukemia
- Ph2NCT01431209 · Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell TransplantUniversity of Nebraska · completed · Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma
- N/ANCT01142674 · T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell LymphomaAssociazione Angela Serra per la ricerca sul cancro · completed · Lymphoma, T-Cell, Peripheral · study chair
- Early Ph1NCT00736450 · Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell LymphomaUniversity of Nebraska · terminated · Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma
- N/ANCT00574626 · Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma
- Ph1NCT00574509 · Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma
- Ph1/Ph2NCT00571493 · VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell LymphomaUniversity of Nebraska · completed · Non-hodgkin's Lymphoma, Mantle Cell Lymphoma
- Ph1/Ph2NCT00572013 · Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent LymphomaUniversity of Nebraska · completed · Lymphoma
- Ph1NCT00243087 · Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)Boehringer Ingelheim · completed · Lymphoma · study chair
- Ph2NCT00004197 · Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma
- Ph2NCT00004192 · Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma, Neutropenia
- Ph3NCT00004112 · Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma
- Ph2NCT00004198 · Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · study chair
- Ph2NCT00007852 · Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma
- Ph3NCT00004874 · Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaUniversity of Nebraska · terminated · Lymphoma · study chair
- Ph2NCT00069966 · Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First RelapseTheradex · unknown · Lymphoma · study chair
- Ph1/Ph2NCT00031642 · Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell TransplantationUniversity of Nebraska · completed · Lymphoma
- Ph2NCT00007865 · Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma
- Ph2NCT00006478 · Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's LymphomaUniversity of Nebraska · terminated · Lymphoma
- Ph2NCT00006695 · Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Amy M Overby · fiscal years 1985 to 2026
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.